These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 18987357

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists.
    Hantgan RR, Stahle MC, Connor JH, Connor RF, Mousa SA.
    J Thromb Haemost; 2007 Mar; 5(3):542-50. PubMed ID: 17166246
    [Abstract] [Full Text] [Related]

  • 4. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins.
    McLane MA, Vijay-Kumar S, Marcinkiewicz C, Calvete JJ, Niewiarowski S.
    FEBS Lett; 1996 Aug 05; 391(1-2):139-43. PubMed ID: 8706902
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
    Leclerc JR.
    Crit Care Med; 2002 May 05; 30(5 Suppl):S332-40. PubMed ID: 12004256
    [Abstract] [Full Text] [Related]

  • 9. Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin.
    Bougie DW, Rasmussen M, Zhu J, Aster RH.
    Blood; 2012 Jun 28; 119(26):6317-25. PubMed ID: 22490676
    [Abstract] [Full Text] [Related]

  • 10. Effect of synthetic peptides corresponding to residues 313-332 of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
    Mitsios JV, Tambaki AP, Abatzis M, Biris N, Sakarellos-Daitsiotis M, Sakarellos C, Soteriadou K, Goudevenos J, Elisaf M, Tsoukatos D, Tsikaris V, Tselepis AD.
    Eur J Biochem; 2004 Feb 28; 271(4):855-62. PubMed ID: 14764102
    [Abstract] [Full Text] [Related]

  • 11. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X, Williams JA, Deadman JJ, Salmon GP, Kakkar VV, Wilkinson JM, Baruch D, Authi KS, Rahman S.
    Biochem J; 1994 Dec 15; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [Abstract] [Full Text] [Related]

  • 12. Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery.
    Rahman S, Flynn G, Aitken A, Patel Y, Hussain F, Lu X, Loftus JC, French D, Wijelath E, Strand K, Savidge GF.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):701-9. PubMed ID: 10642531
    [Abstract] [Full Text] [Related]

  • 13. Variation in the ability of glycoprotein IIb-IIIa antagonists to exert and maintain their inhibitory effects on the binding of fibrinogen.
    Schneider DJ, Baumann PQ, Whitaker DA, Sobel BE.
    J Cardiovasc Pharmacol; 2005 Jul 01; 46(1):41-5. PubMed ID: 15965353
    [Abstract] [Full Text] [Related]

  • 14. Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel alphaIIb-specific alphaIIbbeta3 antagonist.
    Blue R, Kowalska MA, Hirsch J, Murcia M, Janczak CA, Harrington A, Jirouskova M, Li J, Fuentes R, Thornton MA, Filizola M, Poncz M, Coller BS.
    Blood; 2009 Jul 02; 114(1):195-201. PubMed ID: 19414864
    [Abstract] [Full Text] [Related]

  • 15. Differential inhibition of adenosine diphosphate- versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics.
    Weber AA, Schrör K.
    Blood; 2001 Sep 01; 98(5):1619-21. PubMed ID: 11520817
    [Abstract] [Full Text] [Related]

  • 16. An αIIb β3 antagonist prevents thrombosis without causing Fc receptor γ-chain IIa-mediated thrombocytopenia.
    Kuo YJ, Chen YR, Hsu CC, Peng HC, Huang TF.
    J Thromb Haemost; 2017 Nov 01; 15(11):2230-2244. PubMed ID: 28815933
    [Abstract] [Full Text] [Related]

  • 17. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
    Bennett JS, Shattil SJ, Power JW, Gartner TK.
    J Biol Chem; 1988 Sep 15; 263(26):12948-53. PubMed ID: 3417645
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.